MedPath

Online Cognitive Behavior Therapy for Comorbid Sleep Problems in Alcohol Use Disorder

Not Applicable
Conditions
Insomnia
Sleep Disorder
Dyssomnias
Alcohol Use Disorder
Interventions
Behavioral: Cognitive behavior therapy
Registration Number
NCT04402619
Lead Sponsor
Karolinska Institutet
Brief Summary

The main goal is to study the effects of internet-delivered cognitive behavioural therapy with minimum guidance for comorbid sleep problems in alcohol use disorder, in routine addiction care.

Detailed Description

Alcohol use disorder (AUD) is highly prevalent and a major contributor to the global burden of disease. Insomnia symptoms are very common among individuals with AUD, including those in recovery, which may in turn promote alcohol relapse. Specialization and silo phenomena in healthcare organization, separating addiction from other types of psychiatric care, means that individuals with AUD and comorbid sleep problems often have difficulty accessing evidence-treatment for the latter. Offering online treatment for sleep problems to individuals enrolled in traditional routine addiction care is an attractive and pragmatic approach to offering parallel treatments covering the full clinical presentation, which has not yet been evaluated. This pilot and feasibility trial will recruit n=25 from patients in routine addiction care with comorbid sleep problems and AUD, who will complete an online, ten-module, CBT-based treatment program with minimum guidance for sleep problems, tailored for individuals with AUD.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
25
Inclusion Criteria
  • Enrolled patient at Stockholm Center for Dependency Disorders
  • Diagnosed alcohol use disorder
  • Self-rated sleep problem
Read More
Exclusion Criteria
  • Addiction to sedative or hypnotic medication
  • Psychoactive medication not yet 3-month stable in dose
  • Bipolar disorder
  • Psychotic disorder
  • Suicidality
  • Periodic Limb Movement Disorder (PLMD)
  • Sleep apnea
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Online CBTCognitive behavior therapyTen modules with minimum therapist guidance
Primary Outcome Measures
NameTimeMethod
Two-item Sleep Condition IndicatorWeeks 1 through 10 (max 15)

Total score of the two-item SCI, assessing last-week symptoms. Administered on the treatment platform.

Secondary Outcome Measures
NameTimeMethod
Sleep Condition IndicatorChange from baseline (pre-treatment), post-treatment (primary endpoint, 10-15 weeks after baseline), and follow-up three months after baseline..

Change in score on the full and regular SCI. Administered through the online survey tool connected to regular patient records system.

Daily sleep diaryWeeks 1 through 10 (max 15)

Derived measures: last-week average sleep efficiency, time to fall asleep, time awake at night, total sleep time.

Daily alcohol diaryWeeks 1 through 10 (max 15)

Total consumed standard units of alcohol per week, during day and before bedtime

Patient Health Questionnaire-9 (PHQ9)Change from baseline (pre-treatment), post-treatment (primary endpoint, 10-15 weeks after baseline), and follow-up three months after baseline..

Total score

Alcohol Use Disorders Identification Test (AUDIT)Change from baseline (pre-treatment), post-treatment (primary endpoint, 10-15 weeks after baseline), and follow-up three months after baseline..

Total score

Health-related quality of life (EQ5D)Change from baseline (pre-treatment), post-treatment (primary endpoint, 10-15 weeks after baseline), and follow-up three months after baseline..

Total score

Drug Use Disorders Identification Test (DUDIT)Change from baseline (pre-treatment), post-treatment (primary endpoint, 10-15 weeks after baseline), and follow-up three months after baseline..

Total score

Trial Locations

Locations (2)

Stockholm Addiction eClinic (eStöd, Beroendecentrum Stockholm)

🇸🇪

Stockholm, Sweden

Stockholm Centre for Dependency Disorders

🇸🇪

Stockholm, Sweden

© Copyright 2025. All Rights Reserved by MedPath